Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.46 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.45 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.45 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 2/20 | 0.41 |
| ▸ | NOS2 | P35228 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29732491 | 1.00 | MEN1 (0.46) | MEN1KMT2AMAPTGAAPDE10A | |
| Fluoride SCHEMBL10627364 | 0.98 | MEN1 (0.45) | MEN1KMT2AMAPTGAAPDE10A | |
| Hydrochloric Acid SCHEMBL10625153 | 0.98 | MEN1 (0.45) | MEN1KMT2AMAPTGAAPDE10A | |
| SCHEMBL1100716 | 0.94 | MEN1 (0.42) | MEN1KMT2AMAPTGAAPDE10A | |
| SCHEMBL1100717 | 0.91 | MEN1 (0.40) | MEN1KMT2AMAPTGAAPDE10A | |
| Piperazine SCHEMBL28829870 | 0.91 | MEN1 (0.40) | MEN1KMT2AMAPTGAAPDE10A | |
| SCHEMBL15941573 | 0.91 | TXNRD1 (0.45) | MEN1KMT2AMAPTGAAPDE10A | |
| Iodoacetamide SCHEMBL8013117 | 0.86 | MAPT (0.40) | MEN1KMT2AMAPTGAAPDE10A | |
| Alanine SCHEMBL10613024 | 0.85 | MEN1 (0.39) | MEN1KMT2AMAPTGAAPDE10A | |
| Alanine SCHEMBL10613029 | 0.85 | MEN1 (0.39) | MEN1KMT2AMAPTGAAPDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2989 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616656-B2 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2026-05-05 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12584916-B2 | Method for measuring the modulation of the activation of a G protein-coupled receptor with GTP analogues | CISBIO BIOASSAYS (FR) | 2026-03-24 | — | — | US | claimed |
| US-12522656-B2 | Anti-G-protein alpha antibody | CISBIO BIOASSAYS (FR) | 2026-01-13 | — | — | US | claimed |
| WO-2025245370-A1 | FLUORESCENCE-BASED DETECTION METHODS, COMPOUND PANELS, AND ARRAYS INCLUDING THE SAME FOR FLUORESCENCE DETECTION | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4624903-A1 | LIQUID SPRAY ANALYSIS | Rolls-Royce plc (GB) | 2025-10-01 | — | — | EP | claimed |
| US-20250297956-A1 | LIQUID SPRAY ANALYSIS | ROLLS-ROYCE PLC (GB) | 2025-09-25 | — | — | US | claimed |
| US-12292451-B2 | ApoA1 exchange rate assays in serum | CLEVELAND CLINIC FOUNDATION (US) | 2025-05-06 | — | — | US | claimed |
| EP-1498105-A2 | Composition containing at least one conductive polymer and non-film forming rigid particles, corresponding process and use | L'OREAL (FR) | 2005-01-19 | — | — | EP | claimed |
| EP-1498106-A2 | Composition containing a conductive polymer and at least one film-forming polymer, corresponding process and use | L'OREAL (FR) | 2005-01-19 | — | — | EP | claimed |
| EP-1498110-A1 | Composition comprising a conducting polymer and an optical brightener and/or a fluorescent compound | L'OREAL (FR) | 2005-01-19 | — | — | EP | claimed |
| WO-2003093287-A1 | NOVEL METHOD FOR PREPARING ALPHA-GLYCOSYLCERAMIDES, NOVEL ALPHA-GLYCOSYLCERAMIDE DERIVATIVES AND THEIR USES | INSTITUT PASTEUR (FR) | 2003-11-13 | — | — | WO | claimed |
| US-6596544-B1 | Diagnosing atherosclerosis in mammals; obtain tissue sample, incbae with oxidized phospholipid, monitor adjustment in oxidation of phospholipid, absence of adjustment indicates atherosclerosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-07-22 | — | — | US | claimed |
| US-6495687-B1 | ADENOSINE RECEPTORS ARE INVOLVED IN A VAST NUMBER OF PERIPHERAL AND CENTRAL REGULATORY MECHANISMS SUCH AS, FOR EXAMPLE, VASODILATION, CARDIAC DEPRESSION, INHIBITION OF LIPOLYSIS, INHIBITION OF INSULIN RELEASE AND POTENTIATION | ENDACEA, INC. | 2002-12-17 | — | — | US | claimed |
| US-5777133-A | Synthesis of 1, 2-dioxetanes and intermediates therefor | TROPIX, INC. (US) | 1998-07-07 | — | — | US | claimed |
| US-5364764-A | Immunoassay of HIV | MOLECULAR PROBES, INC. (US) | 1994-11-15 | — | — | US | claimed |
| US-5248770-A | Labels such as fluorescent or radioactive compounds | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-09-28 | — | — | US | claimed |
| US-4537718-A | GLUTATHIONE JOINED BY LINKAGE GROUPS TO A SECTROSCOPIC REPORTER | COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1985-08-27 | — | — | US | claimed |